334 related articles for article (PubMed ID: 34830776)
1. The Role of the Innate Immune System in Cancer Dormancy and Relapse.
Chernosky NM; Tamagno I
Cancers (Basel); 2021 Nov; 13(22):. PubMed ID: 34830776
[TBL] [Abstract][Full Text] [Related]
2. Regulation of Metastatic Tumor Dormancy and Emerging Opportunities for Therapeutic Intervention.
Tamamouna V; Pavlou E; Neophytou CM; Papageorgis P; Costeas P
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430404
[TBL] [Abstract][Full Text] [Related]
3. Role of myeloid-derived suppressor cells in metastasis.
Cole K; Pravoverov K; Talmadge JE
Cancer Metastasis Rev; 2021 Jun; 40(2):391-411. PubMed ID: 33411082
[TBL] [Abstract][Full Text] [Related]
4. Myeloid derived suppressor cells and the release of micro-metastases from dormancy.
Khadge S; Cole K; Talmadge JE
Clin Exp Metastasis; 2021 Jun; 38(3):279-293. PubMed ID: 34014424
[TBL] [Abstract][Full Text] [Related]
5. Unveiling cancer dormancy: Intrinsic mechanisms and extrinsic forces.
Liu R; Zhao Y; Su S; Kwabil A; Njoku PC; Yu H; Li X
Cancer Lett; 2024 Jun; 591():216899. PubMed ID: 38649107
[TBL] [Abstract][Full Text] [Related]
6. Breast Cancer Stem Cells as Drivers of Tumor Chemoresistance, Dormancy and Relapse: New Challenges and Therapeutic Opportunities.
De Angelis ML; Francescangeli F; Zeuner A
Cancers (Basel); 2019 Oct; 11(10):. PubMed ID: 31619007
[TBL] [Abstract][Full Text] [Related]
7. An in vitro system to study tumor dormancy and the switch to metastatic growth.
Barkan D; Green JE
J Vis Exp; 2011 Aug; (54):. PubMed ID: 21860375
[TBL] [Abstract][Full Text] [Related]
8. Remodeling the ECM: Implications for Metastasis and Tumor Dormancy.
Di Martino JS; Akhter T; Bravo-Cordero JJ
Cancers (Basel); 2021 Sep; 13(19):. PubMed ID: 34638400
[TBL] [Abstract][Full Text] [Related]
9. EMT and Stemness in Tumor Dormancy and Outgrowth: Are They Intertwined Processes?
Weidenfeld K; Barkan D
Front Oncol; 2018; 8():381. PubMed ID: 30258818
[TBL] [Abstract][Full Text] [Related]
10. Role of myeloid-derived suppressor cells in tumor recurrence.
Cole K; Al-Kadhimi Z; Talmadge JE
Cancer Metastasis Rev; 2023 Mar; 42(1):113-142. PubMed ID: 36640224
[TBL] [Abstract][Full Text] [Related]
11. The Biology and Therapeutic Implications of Tumor Dormancy and Reactivation.
Yadav AS; Pandey PR; Butti R; Radharani NNV; Roy S; Bhalara SR; Gorain M; Kundu GC; Kumar D
Front Oncol; 2018; 8():72. PubMed ID: 29616190
[TBL] [Abstract][Full Text] [Related]
12. Disseminated cancer cells in breast cancer: Mechanism of dissemination and dormancy and emerging insights on therapeutic opportunities.
Ramamoorthi G; Kodumudi K; Gallen C; Zachariah NN; Basu A; Albert G; Beyer A; Snyder C; Wiener D; Costa RLB; Czerniecki BJ
Semin Cancer Biol; 2022 Jan; 78():78-89. PubMed ID: 33626407
[TBL] [Abstract][Full Text] [Related]
13. Metabolic Features of Tumor Dormancy: Possible Therapeutic Strategies.
Pranzini E; Raugei G; Taddei ML
Cancers (Basel); 2022 Jan; 14(3):. PubMed ID: 35158815
[TBL] [Abstract][Full Text] [Related]
14. The Genetic Basis of Dormancy and Awakening in Cutaneous Metastatic Melanoma.
Janowska A; Iannone M; Fidanzi C; Romanelli M; Filippi L; Del Re M; Martins M; Dini V
Cancers (Basel); 2022 Apr; 14(9):. PubMed ID: 35565234
[TBL] [Abstract][Full Text] [Related]
15. Dormancy and cancer stem cells: An enigma for cancer therapeutic targeting.
Talukdar S; Bhoopathi P; Emdad L; Das S; Sarkar D; Fisher PB
Adv Cancer Res; 2019; 141():43-84. PubMed ID: 30691685
[TBL] [Abstract][Full Text] [Related]
16. Tumor cell dormancy as an adaptive cell stress response mechanism.
Vera-Ramirez L; Hunter KW
F1000Res; 2017; 6():2134. PubMed ID: 29263786
[TBL] [Abstract][Full Text] [Related]
17. Tumor dormancy: potential therapeutic target in tumor recurrence and metastasis prevention.
Wang SH; Lin SY
Exp Hematol Oncol; 2013 Oct; 2(1):29. PubMed ID: 24502434
[TBL] [Abstract][Full Text] [Related]
18. Unveiling the role of cellular dormancy in cancer progression and recurrence.
Collignon E
Curr Opin Oncol; 2024 Mar; 36(2):74-81. PubMed ID: 38193374
[TBL] [Abstract][Full Text] [Related]
19. Forging New Therapeutic Targets: Efforts of Tumor Derived Exosomes to Prepare the Pre-Metastatic Niche for Cancer Cell Dissemination and Dormancy.
Bhatia R; Chang J; Munoz JL; Walker ND
Biomedicines; 2023 Jun; 11(6):. PubMed ID: 37371709
[TBL] [Abstract][Full Text] [Related]
20. Minimal residual disease in advanced or metastatic solid cancers: The G0-G1 state and immunotherapy are key to unwinding cancer complexity.
Nicolini A; Rossi G; Ferrari P; Carpi A
Semin Cancer Biol; 2022 Feb; 79():68-82. PubMed ID: 32201368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]